Tris Pharma has expanded its voluntary recall of infant ibuprofen because it may contain overly high concentrations of the drug.
The company, based in Monmouth Junction, New Jersey, announced the move this week.
Tris Pharma has expanded its voluntary recall of infant ibuprofen because it may contain overly high concentrations of the drug.
The company, based in Monmouth Junction, New Jersey, announced the move this week.